REGN475/SAR164877, a nerve growth factor inhibitor, in osteoarthritis patients with moderate to severe knee pain: Results of a phase 2, randomized, double-blind, placebo-controlled study

Authors
Category Primary study
JournalArthritis and Rheumatism
Year 2010
This article has no abstract
Epistemonikos ID: d5a0d14011e027acec61709185619b1a9039ebb1
First added on: Feb 04, 2025